Maravai LifeSciences Holdings Inc (MRVI)
8.97
+0.17
(+1.93%)
USD |
NASDAQ |
May 03, 16:00
8.965
0.00 (0.00%)
After-Hours: 20:00
Maravai LifeSciences Holdings Cash from Operations (TTM): 126.22M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 126.22M |
| September 30, 2023 | 217.77M |
| June 30, 2023 | 313.66M |
| March 31, 2023 | 458.75M |
| December 31, 2022 | 535.98M |
| September 30, 2022 | 495.38M |
| June 30, 2022 | 490.89M |
| Date | Value |
|---|---|
| March 31, 2022 | 492.55M |
| December 31, 2021 | 368.57M |
| September 30, 2021 | 389.26M |
| June 30, 2021 | 335.12M |
| March 31, 2021 | 180.80M |
| December 31, 2020 | 152.19M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
126.22M
Minimum
Dec 2023
535.98M
Maximum
Dec 2022
350.55M
Average
368.57M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| ModivCare Inc | -82.97M |
| Dyadic International Inc | -6.727M |
| Enveric Biosciences Inc | -14.09M |
| Monopar Therapeutics Inc | -7.858M |
| SeaStar Medical Holding Corp | -10.28M |